The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
Authors
Keywords
-
Journal
IUBMB LIFE
Volume 68, Issue 4, Pages 281-292
Publisher
Wiley
Online
2016-02-20
DOI
10.1002/iub.1481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin in Cancer Treatment and Prevention
- (2015) Daniel R. Morales et al. Annual Review of Medicine
- Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway
- (2015) Baiyu Han et al. TUMOR BIOLOGY
- Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction
- (2015) Poliana Camila Marinello et al. TUMOR BIOLOGY
- Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
- (2014) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- A-activated protein kinase is required for cell survival and growth in hela-s3 cellsin vivo
- (2014) Xuhong Song et al. IUBMB LIFE
- Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
- (2014) Eveline A. I. F. Queiroz et al. PLoS One
- Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors
- (2013) Mark E. Welker et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Association of metformin use with cancer incidence and mortality: A meta-analysis
- (2013) Pengpeng Zhang et al. Cancer Epidemiology
- Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
- (2013) S. M. Hadad et al. Clinical & Translational Oncology
- Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
- (2013) Alexander M. Scherbakov et al. EXPERIMENTAL CELL RESEARCH
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
- (2013) M. Cerezo et al. MOLECULAR CANCER THERAPEUTICS
- Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma
- (2013) M Reis-Sobreiro et al. Blood Cancer Journal
- Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
- (2013) Anna Markowska et al. Diabetology & Metabolic Syndrome
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The relationships between snail1 and estrogen receptor signaling in breast cancer cells
- (2012) Alexander M. Scherbakov et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
- (2010) Lev M. Berstein et al. BREAST CANCER RESEARCH AND TREATMENT
- The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
- (2009) A. Vazquez-Martin et al. ANNALS OF ONCOLOGY
- Histological evaluation of AMPK signalling in primary breast cancer
- (2009) Sirwan M Hadad et al. BMC CANCER
- Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
- (2009) K Lundgren et al. BRITISH JOURNAL OF CANCER
- Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
- (2009) R. Rattan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition
- (2009) Theresa Vincent et al. NATURE CELL BIOLOGY
- Rearrangements of the Actin Cytoskeleton and E-Cadherin–Based Adherens Junctions Caused by Neoplasic Transformation Change Cell–Cell Interactions
- (2009) Dmitry V. Ayollo et al. PLoS One
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started